贫血急慢性对急性心肌梗死输血策略的影响:MINT试验二次分析
该研究为MINT多中心随机临床试验的预设亚组分析,纳入3144例急性心梗且随机化时Hb<10 g/dL的患者,比较急性贫血与慢性贫血的预后,并评估贫血急慢性对限制性(Hb<7-8 g/dL)与liberal(Hb<10 g/dL)输血策略效果的影响。结果显示急性贫血与死亡或再发心梗风险升高相关(校正RR 1.25;95%CI 1.05-1.48),但输血策略对急慢性贫血患者的全部结局效应相似。作者结论认为贫血急慢性不应影响输血触发阈值的选择。
要点
- 急性心梗合并贫血患者中,急性贫血(34.3%)较慢性贫血死亡或再发心梗风险更高(校正RR 1.25;95%CI 1.05-1.48)。
- 限制性(Hb<7-8 g/dL)与liberal(Hb<10 g/dL)输血策略对急性贫血和慢性贫血患者的全部结局效应相似。
- 急性贫血定义为首次Hb>13 g/dL(男)或>12 g/dL(女),或首次Hb与随机化时Hb下降≥2 g/dL。
- 作者结论:贫血急慢性不应影响心梗患者输血触发阈值的选取。
- 该分析纳入MINT试验3504例中的3144例(89.7%),来自6国126家医院。
适用人群与场景
- 急性心肌梗死且随机化时血红蛋白<10 g/dL的患者,且入院当日或次日有首次Hb测量值。
- 纳入MINT试验3504例中的3144例(89.7%),平均年龄72.3岁(SD 11.6),男性1715例(54.5%),1型心梗1307例(41.6%)。
诊断标准与关键阈值
- 急性贫血:首次Hb>13 g/dL(男性)或>12 g/dL(女性),或首次Hb与随机化时Hb之间下降≥2 g/dL。
- 慢性贫血:不符合急性贫血标准的其他Hb水平。
- 限制性输血策略:Hb<7-8 g/dL;liberal输血策略:Hb<10 g/dL。
处置流程与药物剂量
- MINT试验将患者随机分配至限制性(Hb<7-8 g/dL)或liberal(Hb<10 g/dL)红细胞输血策略。
- 作者结论:在心梗合并贫血患者中,贫血急慢性不应影响输血触发阈值的选择。
研究设计与关键结果
- 预设亚组分析,纳入MINT多中心随机临床试验中3144例急性心梗伴贫血患者,来自6国126家医院,2017年4月26日至2023年4月14日,30天随访,主要结局盲法裁定。
- 急性贫血1078例(34.3%),与死亡或再发心梗风险升高相关(校正RR 1.25;95%CI 1.05-1.48)。
- 限制性vs liberal输血策略对急性贫血与慢性贫血患者的全部结局效应相似。
- 次要结局包括死亡、再发心梗、心源性死亡、心力衰竭、肺部并发症和大出血事件,均按意向性治疗分析。
证据类型、等级与局限
- 证据类型:多中心随机临床试验(MINT)的预设亚组二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于急性心梗合并贫血患者,贫血急慢性不应作为选择限制性(Hb<7-8 g/dL)或liberal(Hb<10 g/dL)输血触发阈值的依据(作者结论)。
- 急性贫血患者死亡或再发心梗风险更高(校正RR 1.25;95%CI 1.05-1.48),但该风险升高不因输血策略而改变。
指南或共识出处
- Myocardial Ischemia and Transfusion (MINT) trial,ClinicalTrials.gov标识NCT02981407。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: In patients with acute myocardial infarction (MI), limited physiologic adaptation to acute anemia might lead to greater benefit from a liberal red blood cell (RBC) transfusion strategy. Data on such a possible benefit are lacking.
OBJECTIVES: To compare acute anemia with chronic anemia and post-MI outcomes and estimate the differential effect of a restrictive RBC transfusion strategy compared with a liberal strategy on post-MI outcomes according to anemia acuity.
DESIGN, SETTING, AND PARTICIPANTS: A prespecified subgroup analysis of the Myocardial Ischemia and Transfusion (MINT) multicenter randomized clinical trial was conducted in 126 hospitals in 6 countries between April 26, 2017, and April 14, 2023, with 30-day follow-up and blinded adjudication of the primary outcome. The analysis included 3144 of 3504 MINT participants (89.7%) with acute MI, a hemoglobin (Hb) level less than 10 g/dL at randomization, and a first Hb measurement available on the day of or the day following hospital admission.
INTERVENTION: The MINT trial randomized participants to a restrictive (Hb <7-8 g/dL) or liberal (Hb <10 g/dL) RBC transfusion strategy. Acute anemia was defined as having a first Hb value greater than 13 g/dL (men) or 12 g/dL (women), or as having a decrease greater than or equal to 2 g/dL between the first Hb measurement and measurement at randomization. Other Hb levels were categorized as chronic anemia.
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of death or recurrent MI up to 30 days after randomization. Secondary outcomes were death, recurrent MI, cardiac death, heart failure, pulmonary complications, and major bleeding events. Intention-to-treat analysis was performed.
RESULTS: Among 3144 included participants (mean [SD] age, 72.3 [11.6] years; 1715 [54.5%] male; 1307 [41.6%] with type 1 MI), 1078 [34.3%]) had acute anemia. Acute anemia was associated with an increased risk of death or recurrent MI (adjusted risk ratio, 1.25; 95% CI, 1.05-1.48). The effect of a restrictive RBC transfusion strategy compared with a liberal strategy was similar for participants with either acute or chronic anemia for all outcomes.
CONCLUSIONS AND RELEVANCE: In this secondary analysis of the MINT trial, acute anemia was associated with less favorable post-MI outcomes than chronic anemia but did not modify the effects of the randomized transfusion strategy. In patients with anemia and MI, the acuity of anemia should not influence the choice of transfusion trigger.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02981407.
参考来源
- Carrier FM, Cooper HA, Portela GT, et al. Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial. JAMA Netw Open. 2024. PMID: 39485351. doi:10.1001/jamanetworkopen.2024.42361
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。